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or all it has given to science, 
Mendelian genetics is now a sim-
plistic view of inheritance. On top 
of the DNA code lies another genetic 
“language,” the epigenetic code. Wolf Reik 
has built a career of decoding this language.
Reik jumped on the now crowded 
epigenetic bandwagon when it was in its 
infancy, during both his PhD with Rudolf 
Jaenisch in Germany and his postdoc with 
Azim Surani in the UK. At the Babraham 
Institute, where he’s been for 15 years now, 
Reik has delved into the molecular aspects 
of epigenetics and its role in imprinting 
(1)—the developmental control of gene 
expression based on a gene’s maternal 
vs. paternal origin. His group has discov-
ered that imprinting is controlled both by 
noncoding RNAs (2) and by the three-
dimensional arrangement of chromatin 
(3). Along the way, Reik and colleagues 
have uncovered functions for imprinted 
genes in fetal growth (4).
The Reik laboratory is now examin-
ing developmental changes in epigenetic 
marks as cell fates are es-
tablished (5). They are 
also interested in how the 
widespread erasure of epi-
genetic information may 
help reset pluripotency in 
germ cells or in the zygote, 
for example (6).
In a recent conver-
sation, Reik confessed to 
daydreams of a clinical 
practice while he focuses 
on the basic mechanisms behind epige-
netic reprogramming. That reverie, he 
explains, is sated by collaborative projects 
that bring together his molecular studies 
and epigenetics-related human disorders.
SCIENTIFIC IMPRINTS
How did you end up in a scientiﬁ  c career?
I guess partly because both of my parents 
are scientists. [laughs] We were exposed 
to a scientifi  c kind of thinking throughout 
our lives. As a teenager I was interested in 
many different things, including literature 
and music. Studying medicine at that time 
kept a number of my options open.
At university in Germany, I did sev-
eral clinical stints, which I really enjoyed. 
I also worked in a country hospital in Brazil, 
which was both interesting and rewarding. 
It showed me that you can really help 
people even with quite limited technology.
How, then, did you come to pursue 
research rather than a clinical practice?
It was always lurking in the back of my 
mind that I might enjoy research. Then I 
went to a seminar by Rudolf Jaenisch; 
he’s a very good speaker, and he can 
enthuse people. I thought, “Wow, there’s 
a world there that I don’t know about.”
The next day I went to his laboratory 
and said, “Can I please do a PhD here?”
What did you work on in his laboratory?
I was already getting excited about epige-
netic mechanisms of development. The 
word “epigenetics” wasn’t out there yet, 
I don’t think, but it must 
have been in my intuitive 
thinking that that’s what I 
was looking for. There was 
work going on at that time 
on DNA methylation and 
how it controlled the ex-
pression of retroviruses 
that were integrated into 
the genome. I constructed a 
new kind of retroviral vec-
tor, which could be easily 
cloned out again, to look at developmental 
and epigenetic regulation of gene expres-
sion in mammals.
Why did you leave Germany after 
ﬁ  nishing your PhD?
I wanted to learn more about mammalian 
embryogenesis, and the UK at that time 
was probably the key country where many 
laboratories were active in understanding 
embryo development in mammals. So I 
traveled to the UK and visited several 
laboratories and came across Azim Surani, 
who had just discovered the phenomenon 
of imprinting a couple of years earlier.
I thought it was really exciting that 
there was another type of inheritance that 
was not DNA based and was inspired by 
the depths of Azim’s thinking on the new 
principles of epigenetics. When I joined his 
laboratory, he told me that I had to fi  gure out 
the molecular mechanism of this imprinting. 
That was an easy challenge. [laughs]
How’d you meet that challenge?
We put transgenes into the mouse genome, 
in different locations, and we discovered that 
under certain circumstances, the expression, 
the DNA methylation, and the epigenetic 
behavior of the transgene depended on 
whether it was passed down from mother or 
father. That observation put imprinting into 
the molecular world for the fi  rst time.
Upon receiving a ﬁ  ve-year fellowship to 
start a tenure track position, you chose to 
stay in the UK. What’s appealing about 
the UK, and the Babraham speciﬁ  cally, 
for your research?
The UK has a relatively fl  at science struc-
ture, with less of a hierarchical system than 
I was used to in Germany. Hierarchy to 
some extent can inhibit the free fl  ow of 
ideas,  which is so important for science. 
And the Babraham has an excellent tradition 
Reik takes on the dual nature of epigenetic regulation and finds that it 
can satisfy his dual tastes for basic research and medicine.
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in mammalian molecular embryology and 
really good people to collaborate with.
THE PARADOX OF EPIGENETICS
What’s interesting to you about the 
ﬁ  eld of epigenetics and imprinting?
Imprinting is both heritable and reversi-
ble, even though that might sound slightly 
contradictory. It’s shorter term than DNA 
inheritance, and it can be switched from 
being more stable to being more fl  exible. 
How this is achieved is really what fas-
cinates me now.
The reversibility as-
pect struck us when we came 
across epigenetic reprogram-
ming, when the information 
is erased from the genome 
on a large scale during pe-
riods of development. This 
is linked to many different 
biological purposes, one of 
which includes the return of 
developmental pluripotency 
to embryonic cells. You probably need to 
erase epigenetic information on quite a 
large scale to make that possible.
It is also important for inheritance, 
because the large-scale erasure limits the 
amount of epigenetic information that can 
be inherited across generations.
Then how do you save epigenetic 
information that should be inherited?
There are two important scenarios, one of 
which is the idea that the machinery that 
erases the information is targeted very 
specifi  cally to particular locations in the 
genome, for example through sequence-
specifi  c DNA-binding proteins. The other 
is that some genes might specifically 
protect themselves. They might use DNA-
binding proteins that put them into a 
chromatin conformation that is not acces-
sible to the erasure machinery.
Since you’re looking at the geography 
of chromatin, how do you deal with the 
three-dimensional aspect of the work?
The technologies we’re using are based 
on chromatin conformation–capture tech-
nique. The DNA in the nucleus is arranged 
kind of like a bowl of spaghetti, the strands 
intersect and touch each other. If you apply 
a cross-linking agent to the nucleus, it 
links together all the DNA ends that are 
close to each other at that point in time. 
Then we use high-throughput sequencing 
to unravel which bits of the genome were 
in close contact with each other.
What do scientists believe is the 
evolutionary force behind imprinting?
Imprinting has evolved, independently, in 
only placental mammals and seed plants, 
where the endosperm is the equivalent of 
the placenta—a tissue for 
the nutrition of the embryo. 
In both cases, there is an 
important asymmetry: most 
of the resources that the 
embryo receives come from 
the mother, and very little 
come from the father.
The thinking is that 
this asymmetry has driven 
the appearance of imprinted 
genes. Many paternally 
expressed imprinted genes help an embryo 
grow bigger and therefore extract resources 
from the mother to the benefi  t of the child, 
or the paternal genome, in essence.
But the mother has to spread out her 
resources over her reproductive lifespan. 
If she gives all of her resources to one 
child, her other children might lose out. 
Imprinted genes that are maternally ex-
pressed have evolved often to suppress 
fetal growth. It’s a tug-of-war.
THE MEDICAL SLANT
How do you keep a link to your 
enjoyment of clinical work?
The mechanisms behind the erasing of 
epigenetic information are important for 
several practical applications, because if 
you understand how the genome is epige-
netically reprogrammed, you are better 
able to devise stem cell and regenerative 
medicine applications.
You can also help IVF technology, 
which is still quite ineffi  cient; factors that 
determine its effi  ciency are very likely to 
be epigenetic in nature. We have found 
a slightly increased risk of epigenetic 
defects in children born to couples who 
have used IVF or really any form of as-
sisted reproductive technology.
We have also collaborated on stud-
ies on a human imprinting disorder called 
Beckwith-Wiedemann syndrome. In this 
disorder, a particular cluster of imprinted 
genes is deregulated, resulting in much 
larger babies who have an increased risk 
of childhood tumors. We have found that 
paternally expressed imprinted genes are 
overactive in these babies, making them 
grow abnormally.
These types of projects keep my few 
medical brain cells ticking. It also plays 
out in the other direction, since recently we 
found that a particular class of Beckwith-
Wiedemann patients have a mutation in a 
gene we think is important for imprints to 
be established in the germ line. Now we’re 
going back to recreate the mutations in mice. 
We hope to create an animal model of the 
disease and at the same time gain insights 
into mechanistic aspects of imprinting.
Does your own family share your 
interest in science?
My wife’s a molecular immunologist and 
runs a laboratory in Cambridge. My son is 
13, so at the moment he’s only interested 
in football and other sports. My 16-year-
old daughter is quite science oriented, but 
she also studies English literature, so she’s 
keeping her options open, just as I did.
Sounds like that might also be imprinted.
That could well be, actually.
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Reik and his laboratory are interested in 
epigenetic changes that occur as embryos 
develop.
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